These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 39235658)

  • 1. The role of prehabilitation in HNSCC patients treated with chemoradiotherapy.
    Gili R; Gianluca S; Paolo A; Federica S; Paola LC; Simone C; Matteo S; Almalina B; Filippo M; Lucia DM; Vecchio S
    Support Care Cancer; 2024 Sep; 32(10):638. PubMed ID: 39235658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of Phoniatric PREhabilitation in Head and Neck Cancer patients on Aspiration and Preservation of Swallowing (PREHAPS): study protocol of a monocentric prospective randomized interventional outcome-blinded trial.
    Kuenzel J; Duerr S; Vester S; Zeman F; Huppertz G; Koller M; Pfleger G; Woertgen A; Salloum H; Klinkhammer-Schalke M; Pukrop T; Kummer P
    Trials; 2024 Mar; 25(1):211. PubMed ID: 38519961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
    Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
    Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
    Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
    Trials; 2014 Nov; 15():469. PubMed ID: 25432788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review.
    Langius JA; Zandbergen MC; Eerenstein SE; van Tulder MW; Leemans CR; Kramer MH; Weijs PJ
    Clin Nutr; 2013 Oct; 32(5):671-8. PubMed ID: 23845384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment.
    Carmignani I; Locatello LG; Desideri I; Bonomo P; Olmetto E; Livi L; Le Saec O; Coscarelli S; Mannelli G
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2159-2167. PubMed ID: 29978259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Present status of concurrent chemoreadiotherapy in squamous cell carcinoma of head and neck].
    Li XM; Song Q
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):545-9. PubMed ID: 27480307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehabilitation in radiation therapy: a scoping review.
    Flores LE; Westmark D; Katz NB; Hunter TL; Silver EM; Bryan KM; Jagsi R; McClelland S; Silver JK
    Support Care Cancer; 2024 Jan; 32(1):83. PubMed ID: 38177946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.
    de Roest RH; van der Heijden M; Wesseling FWR; de Ruiter EJ; Heymans MW; Terhaard C; Vergeer MR; Buter J; Devriese LA; de Boer JP; Navran A; Hoeben A; Vens C; van den Brekel M; Brakenhoff RH; Leemans CR; Hoebers F
    Radiother Oncol; 2022 Oct; 175():112-121. PubMed ID: 35973619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and tolerance of sequential chemoradiotherapy in squamous cell carcinoma of the head and neck.
    Loo SW; Geropantas K; Tasigiannopoulos Z; Martin C; Roques TW
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):32-40. PubMed ID: 22519981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of life outcome in patients with head and neck squamous cell cancer treated using chemoradiotherapy.
    Tsukada K; Seino Y; Yamashita T
    Auris Nasus Larynx; 2024 Aug; 51(4):674-679. PubMed ID: 38704895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
    Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
    Thomson DJ; Ho KF; Ashcroft L; Denton K; Betts G; Mais KL; Garcez K; Yap BK; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
    Acta Oncol; 2015 Jan; 54(1):88-98. PubMed ID: 25279959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy.
    Suzuki S; Yokota T; Notsu A; Hamauchi S; Onozawa Y; Fushiki K; Oshima K; Kawakami T; Tsushima T; Yasui H; Ogawa H; Onoe T; Kawatani K; Yamazaki K
    Oncologist; 2024 Oct; 29(10):e1315-e1323. PubMed ID: 38979778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional prehabilitation in head and neck cancer: A systematic review of literature.
    De Pasquale G; Mancin S; Matteucci S; Cattani D; Pastore M; Franzese C; Scorsetti M; Mazzoleni B
    Clin Nutr ESPEN; 2023 Dec; 58():326-334. PubMed ID: 38057023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapy.
    Mourad WF; Hu KS; Shasha D; Concert C; Ishihara D; Lin W; Gamez ME; Lukens JN; Shourbaji RA; Ryniak M; Li Z; Culliney BE; Khorsandi AS; Tran T; Jacobson A; Manolidis S; Schantz S; Urken M; Persky MS; Harrison LB
    Anticancer Res; 2013 Dec; 33(12):5511-6. PubMed ID: 24324090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients.
    Fukuda N; Yunokawa M; Fujiwara Y; Wang X; Ohmoto A; Hayashi N; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1322. PubMed ID: 33295110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prehabilitation in head and neck cancer patients: a literature review.
    Loewen I; Jeffery CC; Rieger J; Constantinescu G
    J Otolaryngol Head Neck Surg; 2021 Jan; 50(1):2. PubMed ID: 33407922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.